Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2015 (2015), Article ID 576250, 8 pages
http://dx.doi.org/10.1155/2015/576250
Research Article

Development and Validation of Simple RP-HPLC Method for Intracellular Determination of Fluconazole Concentration and Its Application to the Study of Candida albicans Azole Resistance

Scientific Center of Drug and Medical Technology Expertise JSC, Ministry of Health of Armenia, Komitas 49/4, 0051 Yerevan, Armenia

Received 25 August 2015; Revised 21 October 2015; Accepted 4 November 2015

Academic Editor: Josef Havel

Copyright © 2015 Tigran K. Davtyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Quindós, “Epidemiology of candidaemia and invasive candidiasis. A changing face,” Revista Iberoamericana de Micología, vol. 31, no. 1, pp. 42–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Franz, S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhäuser, “Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 12, pp. 3065–3072, 1998. View at Google Scholar · View at Scopus
  3. C. Garcia-Cuesta, M. G. Sarrion-Pérez, and J. V. Bagán, “Current treatment of oral candidiasis: a literature review,” Journal of Clinical and Experimental Dentistry, vol. 6, no. 5, pp. e576–e582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Arendrup, “Candida and candidaemia. Susceptibility and epidemiology,” Danish Medical Journal, vol. 60, no. 11, Article ID B4698, pp. 1–32, 2013. View at Google Scholar · View at Scopus
  5. L. A. Vale-Silva, A. T. Coste, F. Ischer et al., “Azole resistance by loss of function of the sterol Δ5,6-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 4, pp. 1960–1968, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. White, K. A. Marr, and R. A. Bowden, “Clinical, cellular, and molecular factors that contribute to antifungal drug resistance,” Clinical Microbiology Reviews, vol. 11, no. 2, pp. 382–402, 1998. View at Google Scholar · View at Scopus
  7. M. de Micheli, J. Bille, C. Schueller, and D. Sanglard, “A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance,” Molecular Microbiology, vol. 43, no. 5, pp. 1197–1214, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-G. Chen, Y.-L. Yang, K.-Y. Tseng et al., “Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans,” Fungal Genetics and Biology, vol. 46, no. 9, pp. 714–720, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. R. Basso Jr., C. E. Gast, Y. Mao, and B. Wong, “Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p,” Eukaryotic Cell, vol. 9, no. 6, pp. 960–970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. E. Mansfield, H. N. Oltean, B. G. Oliver et al., “Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi,” PLoS Pathogens, vol. 6, no. 9, Article ID e1001126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. R. Corrêa, C. D. Vianna-Soares, and H. R. N. Salgado, “Development and validation of dissolution test for fluconazole capsules by hplc and derivative UV spectrophotometry,” Chromatography Research International, vol. 2012, Article ID 610427, 8 pages, 2012. View at Publisher · View at Google Scholar
  12. J. C. R. Corrêa and H. R. N. Salgado, “Review of fluconazole properties and analytical methods for its determination,” Critical Reviews in Analytical Chemistry, vol. 41, no. 2, pp. 124–132, 2011. View at Publisher · View at Google Scholar
  13. D. Miron, A. Lange, A. R. Zimmer, P. Mayorga, and E. E. S. Schapoval, “HPLC-DAD for the determination of three different classes of antifungals: method characterization, statistical approach, and application to a permeation study,” Biomedical Chromatography, vol. 28, no. 12, pp. 1728–1737, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Belal, M. K. Sharaf El-Din, M. I. Eid, and R. M. El-Gamal, “Micellar HPLC and derivative spectrophotometric methods for the simultaneous determination of fluconazole and tinidazole in pharmaceuticals and biological fluids,” Journal of Chromatographic Science, vol. 52, no. 4, pp. 298–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-J. Song, W. Li, Z. Wang, D.-D. Tian, and W.-Y. Yin, “Quantitative determination of fluconazole by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) in human plasma and its application to a pharmacokinetic study,” Drug Research, vol. 65, no. 1, pp. 52–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. European Medicines Agency, “Guideline on Bioanalytical Method Validation,” EMEA/CHMP/EWP/192217/2009, 2012, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
  17. Clinical and Laboratory Standards Institute, “Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—ninth edition,” CLSI Document M07-A9, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2012. View at Google Scholar
  18. US DHHS, FDA, and CDER, Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Rat Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, Rockville, Md, USA, 2001.
  19. I. Vandenbossche, M. Vaneechoutte, M. Vandevenne, T. De Baere, and G. Verschraegen, “Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 918–921, 2002. View at Publisher · View at Google Scholar · View at Scopus